AU3569600A - Purification of biological preparations - Google Patents

Purification of biological preparations

Info

Publication number
AU3569600A
AU3569600A AU35696/00A AU3569600A AU3569600A AU 3569600 A AU3569600 A AU 3569600A AU 35696/00 A AU35696/00 A AU 35696/00A AU 3569600 A AU3569600 A AU 3569600A AU 3569600 A AU3569600 A AU 3569600A
Authority
AU
Australia
Prior art keywords
purification
biological preparations
preparations
biological
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU35696/00A
Other languages
English (en)
Inventor
Sean Patrick Gallagher
Deirdre Anne Glenn
Michael Denis Johnston
Mark Jonathon Wilson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cantab Pharmaceuticals Research Ltd
Original Assignee
Cantab Pharmaceuticals Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cantab Pharmaceuticals Research Ltd filed Critical Cantab Pharmaceuticals Research Ltd
Publication of AU3569600A publication Critical patent/AU3569600A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU35696/00A 1999-04-01 2000-04-03 Purification of biological preparations Abandoned AU3569600A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9907553.3A GB9907553D0 (en) 1999-04-01 1999-04-01 Purification of biological preparations
GB9907553 1999-04-01
PCT/GB2000/001256 WO2000059927A1 (en) 1999-04-01 2000-04-03 Purification of biological preparations

Publications (1)

Publication Number Publication Date
AU3569600A true AU3569600A (en) 2000-10-23

Family

ID=10850819

Family Applications (1)

Application Number Title Priority Date Filing Date
AU35696/00A Abandoned AU3569600A (en) 1999-04-01 2000-04-03 Purification of biological preparations

Country Status (7)

Country Link
US (1) US6310186B1 (enExample)
EP (1) EP1165599A1 (enExample)
JP (1) JP2002541155A (enExample)
AU (1) AU3569600A (enExample)
CA (1) CA2365513A1 (enExample)
GB (1) GB9907553D0 (enExample)
WO (1) WO2000059927A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6124201A (en) * 2000-05-03 2001-11-12 Expressive Constructs Inc A method and device for improving protein stability and solubility
WO2004060277A2 (en) * 2002-12-23 2004-07-22 Vical Incorporated Process for purification of plasmid dna
WO2005004894A2 (en) * 2003-05-12 2005-01-20 Expressive Constructs, Inc. Methods for increasing cell and tissue viability
US6913695B2 (en) * 2003-07-08 2005-07-05 Bayer Healthcare Llc Sanitization of chromatographic media
US7427659B2 (en) 2003-10-24 2008-09-23 Amgen Inc. Process for purifying proteins in a hydrophobic interaction chromatography flow-through fraction
EP2409995A3 (en) 2007-02-28 2012-08-15 Lipoxen Technologies Limited Reduction of endotoxin in polysialic acids
CN102215861B (zh) * 2009-06-19 2014-10-08 艾金株式会社 宫颈癌疫苗
SI2462158T1 (en) 2009-08-06 2018-04-30 F. Hoffmann-La Roche Ag Method to improve virus removal in protein purification
WO2015128788A1 (en) * 2014-02-27 2015-09-03 Shantha Biotechnics Private Limited Purification of papillomavirus l2 protein

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5951220A (ja) * 1982-08-02 1984-03-24 Asahi Chem Ind Co Ltd 新規なプラスミノ−ゲン・アクチベ−タ−およびその製法ならびにこれを含有する薬剤
US4707542A (en) * 1983-08-22 1987-11-17 Merck & Co., Inc. Immunogenic HbsAg derived from transformed yeast
US4894439A (en) * 1986-05-22 1990-01-16 Cetus Corporation N-terminal derivatives of tumor necrosis factor purified by microporous PTFE membranes
US5200509A (en) * 1987-04-06 1993-04-06 Celtrix Pharmaceuticals, Inc. Human somatomedin carrier protein subunits and process for producing them; recombinant DNA molecules, hosts, processes and human somatomedin carrier protein-like polypeptides
DE3886517T2 (de) * 1987-08-19 1994-04-21 Central Glass Co Ltd Menschlicher Prourokinase ähnliches Polypeptid.
JPH01238534A (ja) * 1988-03-17 1989-09-22 Mitsui Toatsu Chem Inc エンドトキシンの除去方法
US5429746A (en) * 1994-02-22 1995-07-04 Smith Kline Beecham Corporation Antibody purification

Also Published As

Publication number Publication date
GB9907553D0 (en) 1999-05-26
WO2000059927A1 (en) 2000-10-12
JP2002541155A (ja) 2002-12-03
US6310186B1 (en) 2001-10-30
CA2365513A1 (en) 2000-10-12
EP1165599A1 (en) 2002-01-02

Similar Documents

Publication Publication Date Title
AU2002320185A1 (en) Biological activity of ak155
AU3867400A (en) Methods of using bioelastomers
AU4640400A (en) Analysis of differential protein expression
AU3775600A (en) Customisation of jewellery
AU2091400A (en) Prefabricated biological purification system
AU2001266225A1 (en) Decondensation of dna
AU1608201A (en) Human zven proteins
AU5122500A (en) Detection of biological warfare agents
AU6387000A (en) Serial analysis of genetic alterations
AU3569600A (en) Purification of biological preparations
AU2281601A (en) Treatment of viral infections using levovirinTM
AU5245900A (en) Novel protein and dna thereof
AU6449198A (en) Biological treatment of wastewater
AU2067501A (en) Human oxidoreductase proteins
AU2001278155A1 (en) Fermentation and purification of mycolactones
AU2982000A (en) Preparation of 9-hydrocarbyl-9-phosphabicyclononanes
AU5131699A (en) Cryogranulation of activated protein c
AU1389801A (en) Modification of plants
AU7756900A (en) Treatment of chemical hydrolysates
AUPP385598A0 (en) Purification of antibodies
AU7740100A (en) Efficient implementation of multiprecision arithmetic
AU7711800A (en) Novel uses of 2-bromopalmitate
AU1405001A (en) Treatment of diseases
AU4312201A (en) Isolation and purification of nucleic acids
AU6014200A (en) Disposable jacket

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase